HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The technological transformation of patient-driven human immunology research.

Abstract
New scientific technologies applied to patients with rare diseases are facilitating discoveries about how the human immune system is regulated at the molecular level. Studies of patients with autoimmune lymphoproliferative syndrome (ALPS) or caspase-8 deficiency state (CEDS) demonstrated the ability of gene expression microarray analyses and small interfering RNAs (siRNA) to establish the physiologically important roles of NRAS, caspase-10, and caspase-8 for normal lymphocyte apoptosis and activation. The advent of genomics technologies such as next generation sequencing will complement these and more traditional approaches. These advances are anticipated to accelerate the pace of new discoveries in patients with immunological disorders.
AuthorsHelen C Su
JournalImmunologic research (Immunol Res) Vol. 43 Issue 1-3 Pg. 167-71 ( 2009) ISSN: 0257-277X [Print] United States
PMID18818883 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • RNA, Small Interfering
Topics
  • Animals
  • Biomedical Research (trends)
  • Biomedical Technology (methods)
  • Gene Expression Profiling (methods)
  • Genomics (methods)
  • Humans
  • Immune System (immunology)
  • Immune System Diseases (genetics, immunology, therapy)
  • Oligonucleotide Array Sequence Analysis
  • RNA, Small Interfering (genetics)
  • Rare Diseases (genetics, immunology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: